EUDAMED Registration Mistakes and How to Avoid Them

The European Database on Medical Devices (EUDAMED) is a centralized electronic system established under the EU Medical Device Regulation (MDR) and the In Vitro Diagnostic Medical Device Regulation (IVDR), and there are common mistakes when it comes to registration. As the mandatory system usage deadline of May 2026 approaches (November 28, 2026, for Legacy and Regulation devices placed on the market before mandatory EUDAMED use), manufacturers and other economic operators are preparing to complete actor registration and device data submissions in the relevant EUDAMED modules.  

Starting from May 28, 2026 the four modules mandatory for use include: 

1. Actor registration, 

2. UDI/Devices registration, 

3. Notified bodies and certificates, 

4. Market Surveillance. 

In this article, we provide an overview of common EUDAMED registration mistakes and practical actions manufacturers can take to reduce avoidable delays and rework. 

Learn more about our MDRM service, where we handle both EUDAMED and swissdamed registration support.

Key EUDAMED Registration Mistakes

The most common mistake typically falls into three categories:  

1. Insufficient preparation and weak data governance 

2. Invalid, incomplete, or misaligned data submissions 

3. Ineffective coordination with the EU Authorized Representative 

1. Preparation and Data Governance 

A frequent issue is treating EUDAMED registration as a final administrative task, rather than a structured data management activity. In practice, EUDAMED readiness often requires defined ownership for each data element and an approach to maintaining data throughout the device lifecycle.  

The Data Exists But it is Not Structured for EUDAMED Submission 

Many organizations hold relevant information in technical documentation, quality records, and product lifecycle systems, but not in a format that can be consistently maintained as structured data for EUDAMED submission.  

A practical way to reduce rework is to establish a controlled “source of truth” for EUDAMED data, such as: 

• A Master Data spreadsheet maintained under document control, or 

• A Regulatory Information Management (RIM) module designed for lifecycle maintenance 

This should include a field-level mapping of EUDAMED requirements to internal controlled sources, with clear ownership assigned to each field. 

Basic UDI-DI Strategy is Inconsistently Applied 

Basic UDI-DI generation should already be part of technical documentation and conformity assessment activities; however, grouping strategy may still be misapplied or inconsistently applied across a portfolio. Issues often arise where grouping does not align with intended purpose, risk class, or essential design characteristics.  

Examples of common grouping problems include: 

• Creating excessive Basic UDI-DIs without clear rationale (over-fragmentation) 

• Grouping devices that differ in intended purpose, measurement function, or risk classification (over-grouping) 

Where grouping logic needs to be corrected, manufacturers may need to rework device records and align associated regulatory documentation (e.g. certificates/DoCs), which can create avoidable delays. 

Under-Resourcing the Workstream 

EUDAMED preparation typically requires cross-functional inputs (Regulatory, Quality, Engineering, and commercial functions where naming/portfolio structure is relevant). Assigning ownership to a single function without governance often results in inconsistent datasets and rework.  

2. Data Quality, Validation, and Business Rules 

EUDAMED includes strict technical validation and business rules; however, successful upload does not necessarily confirm that submitted information is accurate or well-aligned with the device’s regulatory status and controlled documentation.  

Incorrect Device Nomenclature Selection (EMDN vs GMDN) 

Many global manufacturers primarily use GMDN, while EUDAMED relies on EMDN. A common EUDAMED registration mistake is relying on automated mapping without regulatory review. 

Key point: EUDAMED requires selection of an appropriate “leaf” (lowest-level) EMDN code when associating nomenclature with a UDI-DI. Manufacturers should apply internal review controls to confirm code appropriateness before submission.  

To reduce avoidable corrections, manufacturers should: 

• Require regulatory review of nomenclature assignments, and 

• Ensure selected codes reflect device intended purpose and portfolio grouping logic 

Legacy Device Misunderstandings 

Legacy device registration has different data requirements, as legacy devices do not have a Basic UDI-DI. EUDAMED assigns a EUDAMED-DI for legacy devices and may derive this from an existing UDI-DI where applicable. In cases where no UDI exists, EUDAMED allocates an identifier accordingly.  

A practical pitfall is incorrectly assigning the legislative framework (Directive vs Regulation) or failing to ensure that the correct relationships between legacy and regulation device records are maintained where the same UDI-DI is used.  

To reduce risk, manufacturers should: 

• Confirm device legislative status before submission (Directive vs Regulation), and 

• Validate record relationships where the same UDI-DI appears across legacy and regulation device registrations 

Economic Operator (“Actor”) Data Misalignment 

Before device registration activities, economic operators must complete relevant actor registration steps to obtain an SRN (where applicable). Common issues include: 

• Legal entity name mismatches across certificates/DoCs and EUDAMED 

• Unclear governance for which legal entity holds which regulatory role 

• Confusion where the same entity performs multiple roles (manufacturer, EAR, importer), which may require separate identification numbers in EUDAMED depending on role configuration  

A practical approach is to define and document: 

• Legal entity role mapping (who is manufacturer, importer, EAR, etc.), and 

• How these roles will be represented consistently across EUDAMED and controlled regulatory documents 

Passing Technical Checks While Failing Business Logic 

EUDAMED includes strict validation rules (e.g., required fields, data types, and dictionary selections). Manufacturers sometimes focus on “getting the file to upload” while overlooking compliance requirements behind the data. 

Even if a submission is technically accepted, missing or misaligned information can still lead to follow-up questions or findings later, including during audits, inspections, or Notified Body review activities. 

3. EU Authorized Representative Coordination 

For non-EU manufacturers, the EU Authorized Representative is required for mandate-related steps in EUDAMED. The EAR must accept/verify the mandate in EUDAMED; the EAR does not automatically control device data unless access rights are specifically granted by the manufacturer.  

Mandate Verification Delays 

A common EUDAMED registration mistake is completing the manufacturer actor registration request and assuming the process is finished. If the EU Authorized Representative is not informed, the mandate acceptance/verification step can remain pending, delaying SRN issuance.  

To reduce avoidable delays, manufacturers should: 

• Confirm mandate workflow responsibilities in advance 

• Align submission timing with the EU Authorized Representative 

• Define escalation routes for time-sensitive requests 

Unclear Expectations Approaching the Deadline 

Service model also matters. If an EU Authorized Representative provides limited operational support, manufacturers should clarify: 

• Responsibilities for mandate processing 

• Expected timelines and escalation routes 

• Communication expectations approaching mandatory usage  

Approaching EUDAMED as a partnership, rather than a last-minute vendor task, reduces risk and prevents avoidable delays. 

Practical Steps to Reduce EUDAMED Registration Mistakes

Manufacturers can reduce common registration EUDAMED mistakes and avoidable delays by implementing the following actions: 

1. Complete a Pre-Submission Data Quality Review 

• Establish a single controlled “Source of Truth” mapping EUDAMED fields to internal controlled sources 

• Assign ownership for each field across functions 

• Identify gaps early and avoid guessing values for regulated fields 

• Confirm dictionary alignment for codes and nomenclature  

2. Coordinate Early with The EU Authorized Representative 

• Confirm mandate workflow steps and timelines 

• Conduct a practical pre-review of key actor data elements (e.g., legal entity data and role alignment)  

3. Use the EUDAMED Playground (Test Environment) 

The European Commission provides a test environment (“Playground”) that mirrors production. This can be used to: 

• Train teams on workflow steps 

• Test validation outcomes before production submission 

• Prepare for bulk upload approaches (often XML-based) where applicable  

Learn More About the EUDAMED Framework with MedEnvoy 

This article provides a detailed overview of common EUDAMED registration mistakes and how to avoid them. MedEnvoy’s regulatory experts can assist manufacturers requiring support with EUDAMED registration and other EU regulatory requirements for medical devices and IVDs. In addition, MedEnvoy offers EU Authorized Representative and importer services. Please reach out if you require assistance by clicking here, and for more information about our consulting services, click here. Learn more about our MDRM service, where we handle both EUDAMED and swissdamed registration support.